Human serum albumin as a clinically accepted cell carrier solution for skin regenerative application

The rules governing Medicinal Products in the European Union necessitates the production of cell-based therapy in good manufacturing practice facilities. The produced cells may need several hours in transportation to reach the application sites. In this study, we investigated four candidate solution...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahin, Hady, Elmasry, Moustafa, Steinvall, Ingrid, Markland, Katrin, Blomberg, Pontus, Sjöberg, Folke, El-Serafi, Ahmed T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468270/
https://www.ncbi.nlm.nih.gov/pubmed/32879384
http://dx.doi.org/10.1038/s41598-020-71553-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468270/
https://www.ncbi.nlm.nih.gov/pubmed/32879384
http://dx.doi.org/10.1038/s41598-020-71553-2

Ejemplares similares